… Patients age ≥ … induction chemotherapy. The authors conducted a retrospective study
comparing the outcomes among these elderly patients with the outcomes among younger patients …

… of elderly patients. The present study suggests that a subgroup of elderly patients with both
… PS and HCT-CI ≤ 2 at presentation may be eligible for intensive induction chemotherapy. …

… We report the results of a prospective study in patients more than 65 … -induction chemotherapy
(arm A) versus "wait and see" and supportive care and mild cytoreductive chemotherapy …

… We retrospectively evaluated 133 patients aged ≥70 years with previously untreated, …
induction chemotherapy at our institution between January 1995 and December 2004. All patients …

… intensity of induction and post-induction chemotherapy reduced the … by elderly patients.
However, additional reasons for the dismal results in elderly patients after intensive induction …

… toxicity between induction chemotherapy followed by concurrent chemoradiotherapy (IC +
CCRT) and concurrent chemoradiotherapy (CCRT) alone in elderly patients with advanced …

… fit old patients included, the clinical results of previous studies involving elderly patients with
… Therefore, we should classify elderly patients according to the CCI, which is reliable and …

… to treat newly diagnosed elderly AML patients with intensive induction chemotherapy, we
ana… of 62 elderly AML patients eligible for and treated with intensive induction chemotherapy in …

… selection bias and attitude of oncologists towards induction chemotherapy … induction
chemotherapy regimen produces high CR rates, is well tolerated and a significant portion of patients …

… induction and consolidation therapy in elderly patients. We retrospectively collected data of
477 patients … The median overall survival (OS) was 339 days in the induction group (n = 266) …